The Pew-Stewart Scholars for Cancer Research Program supports assistant professors of outstanding promise in science relevant to the advancement of a cure for cancer. The award provides $240,000 in flexible support—$60,000 per year for a four-year period.
In line with The Stewart Trust’s mission to invest in innovative, cutting-edge cancer research that may accelerate and advance progress toward a cure for cancer, applications are invited from nominees conducting cancer research. This program is independent from the Pew Scholars Program, and it follows a different set of guidelines and procedures for nominating an applicant whose research is related to cancer.
In 2016, we will name the next Class of five Pew-Stewart Scholars for Cancer Research. For the 3rd series of awards, to be made in 2016, one nomination will be invited from each of the participating institutions. Participating institutions have been selected on the basis of being recognized as a National Cancer Institute (NCI)-designated cancer center. The application for the 2016 awards will open on August 1, 2015.Please read below for more information on the following:
- Nominees must have been awarded a doctorate in a field related to biomedical sciences or medicine.
- As of November 1, 2015, nominees must hold full-time appointments at the rank of assistant professor or the equivalent. (Appointments such as Research Assistant Professor, Adjunct Assistant Professor, Assistant Professor Research Track, Visiting Professor or Instructor are not eligible.)
- On July 1, 2015, candidates must have been in such an appointment for less than three years (not appointed before July 1, 2012), whether or not such an appointment was on a tenure track.
- Candidates may be nominated by their institution only twice. ALL applicants must be nominated by their institution and must complete the 2016 online application.
Based on their performance during their education and training, candidates should demonstrate outstanding promise as contributors in science relevant to the field of cancer. Strong proposals will incorporate particularly creative and innovative approaches in cancer research. Candidates whose work is based on biomedical principles, but brings in concepts and theories from more diverse fields related to cancer, are encouraged to apply. Risk-taking is encouraged. Selection of the successful candidates will be based on a detailed description of the work that the applicant proposes to undertake, evaluations of the candidate’s performance, and notable past accomplishments, including honors, awards and publications. In evaluating the candidates, the Pew-Stewart Advisory Committee gives considerable weight to evidence that the candidate is a successful independent investigator and has published significant work.
Funding from the NIH, other government sources, and project grants from non-profit associations do not pose a conflict with the Pew-Stewart Scholars Program. If you have questions concerning eligibility, please contact Anita Pepper, Program Director, Pew Biomedical Programs at 215-531-8135 in advance of applying.
An award of $60,000 per year will be provided to the sponsoring institution for use by the Scholar over the four-year period, subject to annual review of the Scholar’s progress. Grant agreements will be issued in August 2016. Annual progress reports are required, describing cancer research accomplishments, project status, and future directions. In addition, financial reports are required annually accounting for grant expenditures. Funding for the second, third and fourth years is contingent upon timely submission of acceptable financial and narrative progress reports and attendance at the annual meeting in March during the four-year term.
The awarded funds may be used at the discretion of the Pew-Stewart scholar, for personnel, equipment, supplies, or travel directly related to the Scholar's research and as to best advance his or her cancer research and career. Not more than $10,000 of the annual award may be used for the scholar's salary (including benefits). Should the funds not be immediately required, they may be accumulated (up to a maximum of $100,000 in any given year) and carried over through the four years of the grant period, and, with written approval of the program office, the grant may extended for one additional (fifth) year (without additional funds). Not more than 8 percent of the total award may be allocated for overhead costs. It is expected that Pew-Stewart Scholars will spend at least 80 percent of their time in work related to the accomplishment of their overall research goals. However, Pew provides flexible support to the overall research aims of the Scholar and does not monitor or restrict percentage of effort or time of Pew-Stewart scholars.
During the four-year scholarship term, program participants are required to attend an annual meeting held in March. All expenses for attendees’ travel, lodging, and meals are paid by The Pew Trusts. The meeting provides Pew-Stewart scholars with an opportunity to present their cancer research and for scientific collaboration and exchange with other Pew scholars, Pew fellows and members of the National Advisory Committee.
For the 3rd series of awards, to be made in 2016, one nomination will be invited from the leaders of the following 71 NCI-designated National Cancer Centers:
Abramson Cancer Center, University of Pennsylvania
Albert Einstein Cancer Center, Yeshiva University
Alvin J. Siteman Cancer Center, Washington University School of Medicine and Barnes- Jewish Hospital
Arizona Cancer Center, University of Arizona
Cancer Therapy and Research Center, University of Texas Health Science Center
Case Comprehensive Cancer Center, Case Western Reserve University
Chao Family Comprehensive Cancer Center, University of California, Irvine
City of Hope Comprehensive Cancer Center
Cold Spring Harbor Laboratory Cancer Center
Columbia University Institute for Cancer Genetics, Columbia University
Dan L. Duncan Cancer Center, Baylor College of Medicine
Dana Farber/ Harvard Cancer Center, Harvard University
David H. Koch Institute for Integrative Cancer Research at MIT, Massachusetts Institute of Technology
Duke Cancer Institute, Duke University Medical Center
Fox Chase Cancer Center
Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center
Fred Hutchinson/University of Washington Cancer Consortium
Georgetown Lombardi Comprehensive Cancer Center, Georgetown University
Harold C. Simmons Cancer Center, University of Texas Southwestern Medical Center
Herbert Irving Comprehensive Cancer Center, Columbia University
Holden Comprehensive Cancer Center, University of Iowa
Hollings Cancer Center, Medical University of South Carolina
Huntsman Cancer Institute, University of Utah
Indiana University Melvin and Bren Simon Cancer Center, Indiana University
Jonsson Comprehensive Cancer Center, University of California, Los Angeles
Kimmel Cancer Center, Thomas Jefferson University
Knight Cancer Institute, Oregon Health and Science University
Laura and Isaac Perlmutter Cancer Center at NYU Langone, NYU Langone Medical Center
Ludwig Center for Cancer Genetics & Therapeutics, Sidney Kimmel Comprehensive Cancer Center of the Johns Hopkins University School of Medicine
Marlene and Stewart Greenebaum Cancer Center, University of Maryland, Baltimore
Markey Cancer Center, University of Kentucky
Masonic Cancer Center, University of Minnesota
Massey Cancer Center, Virginia Commonwealth University
Mayo Clinic Cancer Center
Memorial Sloan-Kettering Cancer Center
Moffitt Cancer Center
Norris Cotton Cancer Center at Dartmouth, Dartmouth-Hitchcock Medical Center
Purdue University Center for Cancer Research, Purdue University
Robert H. Lurie Comprehensive Cancer Center, Northwestern University
Roswell Park Cancer Institute
Salk Institute Cancer Center
Sanford-Burnham Medical Research Institute
Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University
St. Jude Children's Research Hospital
Stanford Cancer Institute, Stanford University
The Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine
The Cancer Institute of New Jersey, Rutgers University
The Comprehensive Cancer Center of Wake Forest University
The Jackson Laboratory Cancer Center
The Ohio State University Comprehensive Cancer Center, James Cancer Hospital and Solove Research Institute
The University of Chicago Comprehensive Cancer Center
The University of Kansas Cancer Center
The University of Texas MD Anderson Cancer Center
The Wistar Institute Cancer Center
UAB Comprehensive Cancer Center, University of Alabama at Birmingham
University of California, Davis Comprehensive Cancer Center
University of California, San Diego Moores Cancer Center
University of California, San Francisco Helen Diller Family Comprehensive Cancer Center
University of North Carolina Lineberger Comprehensive Cancer Center
University of Colorado Cancer Center
University of Hawaii Cancer Center
University of Michigan Comprehensive Cancer Center
University of New Mexico Cancer Center
University of Pittsburgh Cancer Institute
University of Virginia Cancer Center
University of Wisconsin Carbone Cancer Center
University of Southern California Norris Comprehensive Cancer Center
Vanderbilt-Ingram Cancer Center,
Winship Cancer Institute, Emory University
Yale Cancer Center, Yale University School of Medicine
The Pew-Stewart National Advisory Committee provides scientific leadership to the program, reviews all applications, and identifies candidates to be recommended to the Pew Board to be named Pew-Stewart Scholars.
Current Members of the National Advisory Committee include:
D. Gary Gilliland, M.D., Ph.D.
Vice Dean and Vice President for Precision Medicine
University of Pennsylvania Health System
University of Pennsylvania
Peter M. Howley, M.D.
Shattuck Professor of Pathological Anatomy
Department of Microbiology and Immunobiology
Harvard Medical School
Tony R. Hunter, Ph.D.
Professor, Molecular and Cell Biology Laboratory
Director, Salk Institute Cancer Center
Salk Institute for Biological Studies
Nickolas Papadopoulos, Ph.D.
Professor, Department of Oncology
Director of Translational Genetics
Ludwig Center for Cancer Genetics & Therapeutics
Sidney Kimmel Comprehensive Cancer Center
Jennifer A. Pietenpol, Ph.D.
Director, Vanderbilt-Ingram Cancer Center
B.F. Byrd Jr. Professor of Oncology
Professor of Biochemistry, Cancer Biology and Otolaryngology